[1]
|
Buskwofie, A., David-West, G. and Clare, C.A. (2020) A Review of Cervical Cancer: Incidence and Disparities. Journal of the National Medical Association, 112, 229-232. https://doi.org/10.1016/j.jnma.2020.03.002
|
[2]
|
何钰, 高峰平. 人乳头瘤病毒基因型与液基细胞学联合检测对宫颈病变的诊断价值[J]. 中国妇幼保健, 2023, 38(19): 3652-3655.
|
[3]
|
饶群仙, 周晖, 林仲秋. 《欧洲妇科肿瘤学会子宫颈癌手术治疗质量指标》解读[J]. 中国实用妇科与产科杂志, 2020, 36(6): 531-535.
|
[4]
|
陈春林, 黎志强. 加强子宫颈癌患者诊治的全程管理[J]. 中国实用妇科与产科杂志, 2021, 37(1): 18-24.
|
[5]
|
Guan, P., Howell-Jones, R., Li, N., Bruni, L. and de Sanjosé, S., Franceschi, S. and Clifford, G.M. (2012) Human Papillomavirus Types in 115,789 HPV-Positive Women: A Meta-Analysis from Cer-vical Infection to Cancer. International Journal of Cancer, 131, 2349-2359. https://doi.org/10.1002/ijc.27485
|
[6]
|
Katki, H.A., Kinney, W.K., Fetterman, B., et al. (2011) Cervical Cancer Risk for 330000 Women Undergoing Concurrent HPV Testing and Cervical Cytology in Routine C2011linical Practice at a Large Managed Care Organization. The Lancet Oncology, 12, 663-672. https://doi.org/10.1016/S1470-2045(11)70145-0
|
[7]
|
王芳, 李卫民, 刘艳丽, 吕爱明. 高危型HPV亚型及病毒载量检测对宫颈癌筛查的价值探究[J]. 实用癌症杂志, 2020, 35(4): 647-650.
|
[8]
|
高万里, 宋风丽, 石鑫, 等. TCT联合高危型HPV检测在宫颈癌筛查中的应用[J]. 中国性科学, 2020, 29(8): 14-18.
|
[9]
|
Wang, L., Song, Q., Liu, Y., et al. (2022) Thinprep Cytologic Test Combined with HPV Typing to Evaluate the Degree of Cervical Diseases and the Relationship between HPV Typing and the Pathological Results of Patients with Atypical Squamous Cells of Undetermined Significance: A Diagnostic Test. Translational Cancer Research, 11, 3277-3286.
https://doi.org/10.21037/tcr-22-2026
|
[10]
|
费华丽, 程易凡, 程晓东, 等. 五种检测方法在宫颈癌及其前期病变筛查中的准确性评估[J]. 中华医学杂志, 2011, 91(5): 309-312.
|
[11]
|
Wieder, H.A., Brucher, B.L., Zimmermann, F., et al. (2016) Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Car-cinoma and Response to Treatment. Journal of Clinical Oncology, 22, 900-908. https://doi.org/10.1200/JCO.2004.07.122
|
[12]
|
徐琭, 崇庆国, 单锦妹. 细胞DNA定量分析联合宫颈细胞涂片在宫颈癌筛查中的应用价值[J]. 实用癌症杂志, 2019, 34(10): 1732-1734.
|
[13]
|
王虹. TCT与HPV联合检查在宫颈癌早期筛查中的应用价值研究[J]. 实用妇科内分泌电子杂志, 2023, 10(6): 100-102.
|
[14]
|
关三华, 胡灵敏. TCT、HPV-DNA、P16蛋白联合检查在早期宫颈癌筛查中的应用价值分析[J]. 中国民康医学, 2022, 34(2): 117-120.
|
[15]
|
Saslow, D., Solomon, D., Lawson, H.W., et al. (2012) American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Preven-tion and Early Detection of Cervical Cancer. CA: A Cancer Journal for Clinicians, 62, 147-172.
https://doi.org/10.3322/caac.21139
|
[16]
|
任婷玉, 廖奕浪, 黄婷婷, 等. 深圳地区女性人乳头瘤病毒的检测和感染情况分析[J]. 实用医学杂志, 2020, 36(7): 969-973.
|
[17]
|
邓六六, 吴莉英, 潘中亚, 黄在菊. 22234例子宫颈高危型HPV感染及亚型分布研究[J]. 实用妇产科杂志, 2020, 36(2): 128-131.
|
[18]
|
张星莹. 阴道镜检查用于宫颈病变筛查的临床价值[D]: [硕士学位论文]. 滨州: 滨州医学院, 2022.
|
[19]
|
Jansen, E., Naber, S.K., Aitken, C.A., et al. (2021) Cost-Effectiveness of HPV-Based Cervical Screening Based on First Year Results in the Netherlands: Amod-ellingstudy. BJOG, 128, 573-582.
https://doi.org/10.1111/1471-0528.16400
|
[20]
|
罗春艳, 刘洁, 刘丽珍, 等. 宫颈病变患者感染高危型HPV分型及其影响因素与模型构建[J]. 中华医院感染学杂志, 2023(23): 3630-3634.
|
[21]
|
Wright Jr., T.C., Schiffman, M., Solomon, D., et al. (2004) Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cer-vical Cytology for Screening. Obstetrics and Gynecology, 103, 304-309.
https://doi.org/10.1097/01.AOG.0000109426.82624.f8
|
[22]
|
李萌辉, 李世霞, 刘俊田. 两种高危型HPV检测方法在宫颈癌早期筛查中的应用[J]. 中国肿瘤临床, 2013, 40(21): 1300-1303.
|